SCHEMBL17157814

SCHEMBL17157814

O=C(C=Cc1ccc(Br)cc1)C(F)(F)C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.49
▸ LMNA P02545 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ESR1 P03372 1/20 0.47
▸ ESR2 Q92731 1/20 0.47
▸ SLC5A1 P13866 1/20 0.45
▸ SLC5A2 P31639 1/20 0.45
▸ CYP1B1 Q16678 2/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ ADAM17 P78536 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17157812 1.00 CYP1A2 (0.49) CYP1A2LMNAALDH1A1NPSR1SMN1; SMN2
SCHEMBL17157757 0.80 HSD17B3 (0.63) LMNAALDH1A1NPSR1CYP1B1MAPT
SCHEMBL17157758 0.80 HSD17B3 (0.63) LMNAALDH1A1NPSR1CYP1B1MAPT
SCHEMBL17157564 0.79 MAOB (0.52) CYP1A2LMNAALDH1A1NPSR1CYP1B1
SCHEMBL17157566 0.79 MAOB (0.52) CYP1A2LMNAALDH1A1NPSR1CYP1B1
SCHEMBL23866749 0.78 LMNA (0.58) CYP1A2LMNAALDH1A1NPSR1SMN1; SMN2
SCHEMBL17157739 0.77 ALDH1A1 (0.39) CYP1A2LMNAALDH1A1NPSR1SMN1; SMN2
SCHEMBL17157737 0.77 ALDH1A1 (0.39) CYP1A2LMNAALDH1A1NPSR1SMN1; SMN2
SCHEMBL17157670 0.76 SMN1; SMN2 (0.47) LMNANPSR1SMN1; SMN2MAPTGPR183
SCHEMBL17157768 0.76 PADI4 (0.39) CYP1A2LMNAALDH1A1SMN1; SMN2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376420-B2 4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same YUHAN CORPORATION (KR) 2016-06-28 — — US disclosed
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME YUHAN CORPORATION (KR) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME NR1H3, NR1H2, NR1H4 CYP1A2 271/4885LMNA 4200/4885ALDH1A1 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback